James D Brierley
Overview
Explore the profile of James D Brierley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peacock H, Van Meensel M, Van Gool B, Silversmit G, Dekoninck K, Brierley J, et al.
Int J Cancer
. 2024 May;
155(7):1212-1224.
PMID: 38728107
The COVID-19 pandemic was associated with a profound decline in cancer diagnoses in 2020 in Belgium. Disruption in diagnostic and screening services and patient reluctance to visit health facilities led...
2.
Janczewski L, Browner A, Cotler J, Nelson H, Ballman K, LeBlanc M, et al.
Cancer
. 2023 Dec;
130(9):1702-1710.
PMID: 38140735
Introduction: The American Joint Committee on Cancer (AJCC) staging system undergoes periodic revisions to maintain contemporary survival outcomes related to stage. Recently, the AJCC has developed a novel, systematic approach...
3.
Janczewski L, Faski J, Nelson H, Gollub M, Eng C, Brierley J, et al.
CA Cancer J Clin
. 2023 Apr;
73(5):516-523.
PMID: 37114458
The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including anal cancer, is the standard for cancer staging in the United States. The AJCC staging criteria...
4.
Said B, Buchan D, Liu Z, Kim J, Hosni A, Brierley J, et al.
Colorectal Dis
. 2022 Nov;
25(4):608-615.
PMID: 36394982
Aim: The aim of this study was to describe the baseline clinical features, treatment patterns and outcomes in rectal squamous cell carcinoma (SCC). Method: This is a retrospective study of...
5.
Wong R, Liu Z, Barry A, Rogalla P, Bezjak A, Brierley J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jul;
114(5):1000-1010.
PMID: 35901981
Purpose: To describe the long-term outcomes of a 5-fraction normal tissue tolerance adapted strategy for the management of oligometastases (OM). Methods And Materials: Patients with histologically confirmed solid tumors, ≤5...
6.
Hosni A, Ringash J, Han K, Liu Z, Brierley J, Wong R, et al.
Dis Colon Rectum
. 2022 Jan;
65(5):642-653.
PMID: 35067501
Background: Maintaining and improving quality of life (QOL) are important goals of anal cancer management. This disease is generally curable, with many long-term survivors. Objective: Long-term QOL after chemoradiation for...
7.
Lukovic J, Kim J, Liu Z, Cummings B, Brierley J, Wong R, et al.
Dis Colon Rectum
. 2022 Jan;
65(2):189-197.
PMID: 34990422
Background: Anal adenocarcinoma is a rare clinical entity for which the optimal management is not defined. Objective: This study aimed to describe the multidisciplinary management and outcomes of patients with...
8.
Lukovic J, Petrovic I, Liu Z, Armstrong S, Brierley J, Tsang R, et al.
Front Endocrinol (Lausanne)
. 2022 Jan;
12:795184.
PMID: 34975765
Objective: The main objective of this study was to review the clinicopathologic characteristics and outcome of patients with oncocytic papillary thyroid carcinoma (PTC) and oncocytic poorly differentiated thyroid carcinoma (PDTC)....
9.
Khwaja S, Thipphavong S, Kirsch R, Menezes R, Kennedy E, Brierley J, et al.
Eur J Radiol
. 2021 Mar;
138:109628.
PMID: 33721764
Purpose: To evaluate the performance of a multiparametric (mp) MRI scoring system for assessment of tumour response in patients with locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (CRT). Method:...
10.
Byrd D, Brierley J, Baker T, Sullivan D, Gress D
CA Cancer J Clin
. 2020 Nov;
71(2):140-148.
PMID: 33156543
Until recently, cancer registries have only collected cancer clinical stage at diagnosis, before any therapy, and pathological stage after surgical resection, provided no treatment has been given before the surgery,...